Ambeed.cn

首页 / / / Sirtuin / CAY10602

CAY10602 {[allProObj[0].p_purity_real_show]}

货号:A424556

CAY10602是一种 SIRT1 的激活剂,可抑制 THP-1 细胞中脂多糖(LPS)对 NF-κB 的 TNF-α 依赖性诱导。

CAY10602 化学结构 CAS号:374922-43-7
CAY10602 化学结构
CAS号:374922-43-7
CAY10602 3D分子结构
CAS号:374922-43-7
CAY10602 化学结构 CAS号:374922-43-7
CAY10602 3D分子结构 CAS号:374922-43-7
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

CAY10602 纯度/质量文件 产品仅供科研

货号:A424556 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 SIRT1 SIRT2 SIRT3 SIRT5 SIRT6 SIRT7 Sirtuin 其他靶点 纯度
Selisistat ++++

SIRT1, IC50: 38 nM

99%+
Resveratrol 98%
Inauhzin p53 99%+
Suramin sodium salt +++

SirT1, IC50: 297 nM

++

SirT5, IC50: 22 μM

99%+
Salermide 99%
Quercetin Dihydrate 95%
Sirtinol +

SIRT1, IC50: 131 μM

++

SIRT2, IC50: 38 μM

98%+
AGK2 +++

SIRT2, IC50: 3.5 μM

99%+
Tenovin-3 p53 99%+
3-TYP ++++

SIRT1, IC50: 88 nM

++++

SIRT2, IC50: 92 nM

++++

SIRT3, IC50: 16 nM

95%
Tenovin-6 ++

SIRT1, IC50: 21 μM

++

SIRT2, IC50: 10 μM

+

SIRT3, IC50: 67 μM

p53 99%+
SirReal2 +++

SIRT2, IC50: 140 nM

99%+
Thiomyristoyl ++++

SIRT2, IC50: 28 nM

99%+
Et-29 98%
OSS_128167 +

SIRT1, IC50: 1578 μM

+

SIRT2, IC50: 751 μM

+

SIRT6, IC50: 89 μM

98%
SIRT7 inhibitor 97491 +++

SIRT7, IC50: 325 nM

97%
Nicotinamide 99+%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

CAY10602 生物活性

描述 CAY10602 is a SIRT1 activator that dose-dependently inhibits the NF-κB-dependent induction of TNF-α by LPS in THP-1 cells at concentrations ranging from 20 to 60 μM. CAY10602 has a significant effect on fat mobilisation in differentiated adipocytes and possesses anti-obesity and/or antidiabetic properties[1].

CAY10602 细胞实验

Cell Line
Concentration Treated Time Description References
HT22 neuronal cells 10 μM 24 h To evaluate the effect of CAY10602 on ammonia-induced neurotoxicity, results showed that CAY10602 reduced ammonia-induced apoptosis and ROS levels in HT22 cells. Oxid Med Cell Longev. 2021 Oct 12;2021:5522708
BV2 microglial cells 10 μM To evaluate the effect of CAY10602 on NLRP3 inflammasome activation, results showed that CAY10602 inhibited LPS and ATP-induced NLRP3 inflammasome activation. Oxid Med Cell Longev. 2021 Oct 12;2021:5522708
BV2 microglial cells 1, 4, 8, 10 μM 8 h To evaluate the activation effect of CAY10602 on SIRT1, results showed that CAY10602 upregulated the protein expression of SIRT1 in a dose-dependent manner. Oxid Med Cell Longev. 2021 Oct 12;2021:5522708
vascular smooth muscle cells (VSMCs) 10 µmol·L−1 24 h To verify the effect of SIRT1 activator CAY10602 on PA-induced mitochondrial dysfunction, the results showed that CAY10602 could further promote the effect of Deh on SIRT1 expression and inhibit Drp1 expression and mitochondrial dysfunction. Lipids Health Dis. 2025 May 24;24(1):187
HepG2 cells 20 μM 2 h CAY10602, as a SIRT-1 activator, reversed the OA-induced decrease in HepG2 cell viability, reduced apoptosis and lipid accumulation, and alleviated ROS production. Lipids Health Dis. 2021 Apr 26;20(1):40

CAY10602 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Wistar rats Thioacetamide (TAA)-induced hepatic encephalopathy model Intraperitoneal injection 5 mg/kg Once daily for 3 days To evaluate the therapeutic effect of CAY10602 on hepatic encephalopathy, results showed that CAY10602 alleviated liver injury, improved neurological decline, reduced microglial activation and brain oxidative stress, and improved the survival rates of HE rats. Oxid Med Cell Longev. 2021 Oct 12;2021:5522708

CAY10602 参考文献

[1]Nayagam VM, et al. SIRT1 modulating compounds from high-throughput screening as anti-inflammatory and insulin-sensitizing agents. J Biomol Screen. 2006 Dec;11(8):959-67.

CAY10602 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.39mL

0.48mL

0.24mL

11.95mL

2.39mL

1.19mL

23.90mL

4.78mL

2.39mL

CAY10602 技术信息

CAS号374922-43-7
分子式C22H15FN4O2S
分子量 418.44
SMILES Code NC1=C(S(=O)(C2=CC=CC=C2)=O)C3=NC4=CC=CC=C4N=C3N1C5=CC=C(F)C=C5
MDL No. MFCD02236691
别名
运输蓝冰
InChI Key CSFVFDHRYKBBPD-UHFFFAOYSA-N
Pubchem ID 1915791
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Keep in dark place, inert atmosphere, store in freezer, under -20°C

溶解方案

DMSO: 40 mg/mL(95.59 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。